Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cb9f654ff-qc88w Total loading time: 0 Render date: 2025-08-11T21:56:14.561Z Has data issue: false hasContentIssue false

20 - The neuropsychology of chronic drug abuse

from Part IX - Drug use and abuse

Published online by Cambridge University Press:  19 January 2010

By
Robert D Rogers  and
Trevor W Robbins
Edited by
Maria A. Ron  and
Trevor W. Robbins
Robert D Rogers
Affiliation:
University of Oxford, Oxford, UK
Trevor W Robbins
Affiliation:
University of Cambridge, Cambridge, UK
Maria A. Ron
Affiliation:
Institute of Neurology, London
Trevor W. Robbins
Affiliation:
University of Cambridge
Get access

Summary

Introduction

There are at least two ways in which cognitive impairments might contribute to drug misuse and drug dependence or addiction. Cognitive impairments, perhaps involving heightened impulsivity, may facilitate drug-seeking behaviour but also undermine the extent to which drug users are able to assimilate and benefit from treatment programmes that often have strong educational and cognitive components (McCrady and Smith 1986; Majewska 1996).

Recent research has seen a rapid expansion of the investigation of neurocognitive deficits in drug abusers and on the relationship between these deficits and neurochemical, morphological and functional pathologies associated with chronic drug use. This research is now able to call upon advances from several areas of cognitive neuroscience, encompassing neuroanatomy and molecular pharmacology (Gurevich and Joyce 1999; Ongur and Price 2000), psychological theory concerning the nature of motivated action and reinforcement mechanisms as they relate to drugs of abuse (see Altman et al. 1996; Everitt et al. 2001 for reviews), and imaging methodologies (Breiter et al. 1997; Volkow et al. 1997; Gollub et al. 1998; Liu et al. 1998) and event-based electroencephalography (McKetin and Solowij 1999) that allow investigation of the physiological correlates of cognitive and emotional activity in the brain. Moreover, the scope of this research is expanding with the preliminary investigation of neurocognitive deficits associated with drugs, such as ketamine, whose potential for abuse is only recently becoming apparent (Curran and Morgan 2001).

Information

Type
Chapter
Information
Disorders of Brain and Mind , pp. 447 - 467
Publisher: Cambridge University Press
Print publication year: 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Allen, D N, Goldstein, G and Seaton, B E (1997). Cognitive rehabilitation of chronic alcohol abusers. Neuropsychol Rev, 7, 21–39CrossRefGoogle Scholar
Altman, J, Everitt, B J, Glautier, S et al. (1996). The biological, social and clinical bases of drug addiction: commentary and debate. Psychopharmacology, 125, 285–345CrossRefGoogle Scholar
Anderson, S W, Damasio, H, Jones, R D and Tranel, D (1991). Wisconsin Card Sorting Test performance as a measure of frontal lobe damage. J Clin Exp Neuropsychol, 13, 909–22Google Scholar
Bassoa, M R and Bornstein, R A (2000). Neurobehavioral consequences of substance and HIV infection. J Psychopharmacol, 14, 228–37Google Scholar
Beatty, W W, Katzung, V M, Moreland, V J and Nixon, S J (1995). Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend, 37, 247–53CrossRefGoogle Scholar
Bechara, A, Damasio, A R, Damasio, H and Anderson, S W (1994). Insensitivity to future consequences following damage to human prefrontal cortex. Cognition, 50, 7–15CrossRefGoogle Scholar
Bechara, A, Dolan, S, Denburg, N, Hindes, A, Anderson, S W and Nathan, P E (2001). Decision-making deficits, linked to dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia, 39, 376–89Google Scholar
Berry, J, Gorp, W, Herzberg, D S et al. (1993). Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend, 32, 231–7Google Scholar
Block, R I and Ghoneim, M M (1993). Effects of chronic marijuana use on human cognition. Psychopharmacology, 110, 219–28CrossRefGoogle Scholar
Block, R I, O'Leary, D S, Ehrhardt, J C et al. (2000 a). Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport, 11, 491–6Google Scholar
Block, R I, O'Leary, D S, Hichwa, R D et al. (2000 b). Cerebellar hypoactivity in frequent marijuana users. NeuroReport, 11, 749–53Google Scholar
Bolla, K I, McCann, U D and Ricaurte, G A (1998). Impaired memory function in (±) 3, 4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) users. Neurology, 51, 1532–7Google Scholar
Bolla, K I, Rothman, R and Cadet, J L (1999). Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci, 11, 361–9Google Scholar
Bolla, K I, Funderburk, F R and Cadet, J L (2000). Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology, 54, 2285–92CrossRefGoogle Scholar
Breiter, H C, Gollub, R L, Weisskoff, R M et al. (1997). Acute effects of cocaine on human brain activity and emotion. Neuron, 19, 591–611CrossRefGoogle Scholar
Bruhn, P and Maage, N (1975). Intellectual and neuropsychological functions in young men with heavy and long-term patterns of drug abuse. Am J Psychiatry, 132, 397–401CrossRefGoogle Scholar
Cardinal, R N, Pennicott, D R, Sugathapala, C L, Robbins, T W and Everitt, B J (2001). Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science, 292, 2499–501Google Scholar
Carroll, K M, Rounsaville, B J and Bryant, K J (1993). Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. J Stud Alcohol, 54, 199–208Google Scholar
Castner, S A and Goldman-Rakic, P S (1999). Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology, 20, 10–28CrossRefGoogle Scholar
Commins, D L, Vosmer, G, Virus, G M, Woolverton, W L, Schuster, C R and Seiden, L S (1987). Biochemical and histological evidence methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther, 241, 338–45Google Scholar
Cooper J R, Bloom F E and Roth R H (1996). The Biochemical Basis of Neuropharmacology, 7th edn. New York: Oxford University Press
Croft, R J, Mackay, A J, Mills, A T and Gruzelier, J G (2001). The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology, 153, 373–9Google Scholar
Curran, H V and Morgan, C (2001). Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction, 95, 575–90Google Scholar
Curran, H V and Travill, R A (1997). Mood and cognitive effects of +/-3,4-methylenedioxyamphetamine (MDMA, ‘ecstasy’): week-end ‘high’ followed by mid-week low. Addiction, 92, 821–31Google Scholar
Dias, R, Robbins, T W and Roberts, A C (1996). Dissociation in prefrontal cortex of affective and attentional shifts. Nature, 380, 69–72CrossRefGoogle Scholar
Ehrenreich, H, Rinn, T, Kunert, H J et al. (1999). Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology, 142, 295–301CrossRefGoogle Scholar
Eisch, A J, Barrot, M, Schad, C A, Self, D W and Nestler, E J (2000). Opiates inhibit neurogenesis in the adult rat hippocampus. Neurotoxicol Teratol, 97, 7579–84Google Scholar
Elliott, R, Sahakian, B J, Matthews, K, Bannerjea, A, Rimmer, J and Robbins, T W (1997). Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology, 131, 196–206CrossRefGoogle Scholar
Everitt, B J, Dickinson, A and Robbins, T W (2001). The neuropsychological basis of addictive behaviour. Brain Res Rev, 36, 129–38Google Scholar
Feldman R S, Meyer J S and Quenzer L (1997). Principles of Neuropsychopharmacology. Sunderland, MA: Sinauer Associates
Fletcher, J M, Page, B, Francis, D J et al. (1996). Cognitive correlates of long-term cannabis use in Costa Rica men. Arch Gen Psychiatry, 53, 1051–7Google Scholar
Fried, P A and Smith, A M (2001). A literature review of the consequences of prenatal marijuana exposure: an emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol, 23, 1–11CrossRefGoogle Scholar
Gollub, R L, Breiter, H C, Kantor, H et al. (1998). Cocaine decreases cortical cerebral blood flow but does not obscure regional activation in functional magnetic resonance imaging in human subjects. J Cereb Blood Flow Metab, 18, 724–724Google Scholar
Gouzoulis-Mayfrank, E, Daumann, J, Tuchtenhagen, F et al. (2000). Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry, 68, 719–25CrossRefGoogle Scholar
Grant, I, Adams, K M, Carlin, A S, Rennick, P M, Judd, L L and Schoof, K (1978). Collaborative neuropsychological study of polydrug users. Arch Gen Psychiatry, 35, 1063–74Google Scholar
Grant, S, Contoreggi, C and London, E D (2000). Drug abusers show impaired performance in a laboratory test of decision-making. Neuropsychologia, 38, 1180–7CrossRefGoogle Scholar
Gurevich, E V and Joyce, J N (1999). Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology, 20, 60–80Google Scholar
Herkenham, M, Lynn, A B, Little, M D et al. (1990). Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA, 87, 1932–6CrossRefGoogle Scholar
Hill, S Y and Mikhael, M A (1979). Computerised transaxial tomographic and neuropsychological evaluations in chronic alcohol and heroin abusers. Am J Psychiatry, 136, 598–602Google Scholar
Janowsky, D S and Risch, C (1979). Amphetamine psychosis and psychotic symptoms. Psychopharmacology, 65, 73–7CrossRefGoogle Scholar
Jatlow, P (1995). Cocaethylene. What is it?Am J Clin Pathol, 104, 120–1Google Scholar
Jentsch, J D and Taylor, J R (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology, 146, 373–90Google Scholar
Jentsch, J D and Taylor, J R (2001). Impaired inhibition of conditioned responses produced by sub-chronic administration of phencyclidine to rats. Neuropsychopharmacology, 24, 66–74Google Scholar
Jentsch, J D, Dazzi, L, Chhatwal, J P, Verrico, C D and Roth, R H (1998 a). Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats. Neurosci Lett, 258, 175–8Google Scholar
Jentsch, J D, Verrico, C D, Dung, L and Roth, R H (1998 b). Repeated exposure to 9-tetrahydrocannabinol reduces prefrontal cortical dopamine in the rat. Neurosci Lett, 246, 169–72Google Scholar
Jentsch, J D, Taylor, J R, Redmond, D E Jr, Elsworth, J D, Youngren, K D and Roth, R H (1999). Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys. Psychopharmacology, 142, 78–84CrossRefGoogle Scholar
Jentsch, J D, Roth, R H and Taylor, J R (2000). Object retrieval/detour deficits in monkeys produced by prior subchronic phencyclidine administration: evidence for cognitive impulsivity. Biol Psychiatry, 48, 415–24CrossRefGoogle Scholar
Jentsch, J D, Olausson, P, Garza, R and Taylor, J R (2002). Impairments of learning reversal and response perseveration after repeated, intermittent cocaine administration in monkeys. Neuropsychopharmacology, 26, 183–90Google Scholar
Koelega, H S (1993). Stimulant drugs and vigilance performance: a review. Psychopharmacology, 111, 1–16Google Scholar
Krystal, J H, Price, L H, Opsahl, C, Ricaurte, G A and Heninger, G R (1992). Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function. Am J Drug Alcohol Abuse, 18, 331–41CrossRefGoogle Scholar
Lawston, J, Borella, A, Robinson, J K and Whitaker-Azmitia, P M (2000). Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2. Brain Res, 877, 407–10Google Scholar
Lee A C H, Owen A M, Rogers R D, Sahakian B J and Robbins T W (2000). Utility of CANTAB in functional neuroimaging. In Functional Neuroimaging in Child Psychiatry, ed. M Ernst and J M Rumsey, pp. 366–78. Cambridge: Cambridge University Press
Lewis D A (2001). The catecholamine innervation of the primate cerebral cortex. In Stimulant Drugs and ADHD: Basic and Clinical Neuroscience, ed. M V Solanto, A F T Arnsten and F X Castellanos, pp. 77–103. New York: Oxford University Press
Liu, X, Matochik, J A, Cadet, J L and London, E D (1998). Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology, 18, 243–52CrossRefGoogle Scholar
London, E D, Ernst, M, Grant, S, Bonson, K and Weinstein, A (2000). Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex, 10, 334–42Google Scholar
Madden, G J, Petry, N M, Badger, G J and Bickel, W K (1997). Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp Clin Psychopharmacol, 5, 256–62CrossRefGoogle Scholar
Majewska, M D (1996). Cocaine addiction as a neurological disorder: implication for treatment. NIDA Res Monogr, 1631–2Google Scholar
McCann, U D and Molliver, M E (2001). ‘Ecstasy’ and serotonin neurotoxicity. New findings raise more questions. Arch Gen Psychiatry, 58, 901–6Google Scholar
McCann, U D, Szabo, Z, Scheffel, U et al. (1998). Positron emission tomographic evidence of toxic effect of MDMA (‘ecstasy’) on brain serotonin in human beings. Lancet, 352, 1433–7Google Scholar
McCann, U D, Mertl, M, Eligulahvilli, and Ricaurte, G A (1999). Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) users: a controlled study. Psychopharmacology, 143, 417–25Google Scholar
McCrady, B S and Smith, D E (1986). Implications of cognitive impairment for the treatment of alcoholism. Alcohol Clin Exp Res, 10, 145–59CrossRefGoogle Scholar
McKetin, R and Solowij, N (1999). Event-related potential indices of auditory selective attention in dependent amphetamine users. Biol Psychiatry, 45, 1488–97Google Scholar
Morgan, M J (1998). Recreational use of ecstasy (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology, 19, 253–64Google Scholar
Morgan, M J (1999). Memory deficits associated with recreational use of ‘ecstasy’ (MDMA). Psychopharmacology, 141, 30–6CrossRefGoogle Scholar
Morgan, M J (2000). Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology, 152, 230–48CrossRefGoogle Scholar
O'Malley, S, Adamse, M, Heaton, R K and Gawin, F H (1992). Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse, 18, 131–44CrossRefGoogle Scholar
Ongur, D and Price, J L (2000). The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex, 10, 206–19Google Scholar
Ornstein, T J, Iddon, J L, Baldacchino, A M et al. (2000). Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology, 23, 113–26CrossRefGoogle Scholar
Parrott, A C, Lees, A, Garnham, N J, Jones, M and Wesnes, K (1998). Cognitive performance in recreational users of MDMA or ecstasy. J Psychopharmacol, 12, 79–83CrossRefGoogle Scholar
Pope, H G, Gruber, A J and Yurgelun-Todd, D (1995). The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend, 38, 25–34Google Scholar
Pope, H G, Gruber, A J, Hudson, J I, Huesis, M A and Yurgelun-Todd, D (2001). Neuropsychological performance of long-term cannabis users. Archiv Gen Psychiatry, 58, 909–15CrossRefGoogle Scholar
Rahman, S, Sahakian, B J, Hodges, J R, Rogers, R D and Robbins, T W (1999). Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain, 122, 1469–93CrossRefGoogle Scholar
Rahman, S, Sahakian, B J, Cardinal, R, Rogers, R D and Robbins, T W (2001). Decision-making and neuropsychiatry. Trends Cognit Sci, 5, 271–7CrossRefGoogle Scholar
Reneman, L, Lavalaye, J, Schmand, B et al. (2001). Archiv Gen Psychiatry, 58, 901–6
Ricaurte, G A, Schuster, C R and Seiden, L S (1984). Long-term effects of repeated methamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain, 193, 153–63Google Scholar
Ricaurte, G A, Martello, A, Katz, J L and Martello, M B (1992). Lasting effects of (±)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther, 261, 616–22Google Scholar
Robbins, T W and Everitt, B J (1999). Drug addiction: bad habits add up. Nature, 398, 567–70CrossRefGoogle Scholar
Robinson, J E, Heaton, R K and O'Malley, S (1999). Neuropsychological functioning in cocaine abusers with and without alcohol dependence. J Int Neuropsychol Soc, 5, 10–19Google Scholar
Robinson, T E and Kolb, B (1999 a). Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci, 11, 1598–604Google Scholar
Robinson, T E and Kolb, B (1999 b). Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse, 33, 160–2Google Scholar
Rodgers, J (2000). Cognitive performance amongst recreational users of ‘ecstasy’. Psychopharmacology, 151, 19–24Google Scholar
Rogers, R D, Blackshaw, A J, Middleton, H C et al. (1999 a). Tryptophan depletion impairs stimulus–reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology, 146, 482–91Google Scholar
Rogers, R D, Everitt, B J, Baldacchino, A et al. (1999 b). Dissociating deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology, 20, 322–9Google Scholar
Roselli, M and Ardila, A (1996). Cognitive effects of cocaine and polydrug abuse. J Clin Exp Neuropsychol, 18, 122–35CrossRefGoogle Scholar
Rosenthal, T L, Edwards, N B, Ackerman, B J, Knott, D H and Rosenthal, R H (1990). Substance abuse patterns reveal contrasting personality traits. J Subst Abuse, 2, 255–63CrossRefGoogle Scholar
Rosenzweig, M R and Bennett, E L (1996). Psychobiology of plasticity: effects of training and experience on brain and behavior. Behav Brain Res, 78, 57–65Google Scholar
Rounsaville, B J (1982). Neuropsychological functioning in opiate addicts. J Nerv Ment Dis, 170, 209–16Google Scholar
Rusted, J M, Mackee, A, Williams, R and Willner, P (1998). Deprivation state but not nicotine content of the cigarette affects responding by smokers on a progressive ratio task. Psychopharmacology, 140, 411–17CrossRefGoogle Scholar
Sahakian, B J and Owen, A M (1992). Computerised assessment in psychiatry using CANTAB: discussion paper. J R Soc Med, 85, 399–402Google Scholar
Semple, D M, Ebmeier, K P, Glabus, M F, O'Carroll, R E and Johnstone, E C (1999). Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users. Br J Psychiatry, 175, 63–9Google Scholar
Solowij, N (1995). Do cognitive impairments recover following cessation of cannabis use?Life Sci, 56, 2119–26Google Scholar
Solowij N (1998). Cannabis and Cognitive Functioning. Cambridge: Cambridge University Press
Solowij, N, Michie, P T and Fox, A M (1995). Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry, 37, 731–9Google Scholar
Strickland, T L, Mena, I, Villanueva-Meyer, J et al. (1993). Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci, 5, 419–27CrossRefGoogle Scholar
Strickland, T L, Stein, R A, Khalsa, H and Andre, K (1997). Gender differences in neuropsychological test performance among cocaine abusers. Arch Clin Neuropsychol, 12, 410–11Google Scholar
Villemagne, V, Yuan, J, Wong, D F et al. (1998). Brain dopamine in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci, 18, 419–27CrossRefGoogle Scholar
Volkow, N D and Fowler, J S (2000). Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex, 10, 318–25Google Scholar
Volkow, N D, Hitzemann, R, Wang, G-J et al. (1992). Long-term frontal brain metabolic changes in cocaine abusers. Synapse, 11, 184–90CrossRefGoogle Scholar
Volkow, N D, Fowler, J S, Wang, G J et al. (1993). Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse, 14, 169–77CrossRefGoogle Scholar
Volkow, N D, Gillespie, H, Mullani, N et al. (1996). Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Res, 67, 29–38CrossRefGoogle Scholar
Volkow, N D, Wang, G-J, Fischman, M W et al. (1997). Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature, 386, 827–30CrossRefGoogle Scholar
Wilson, J M, Kalasinsky, K S, Levey, A I et al. (1996 a). Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med, 2, 699–703Google Scholar
Wilson, J M, Levey, A I, Bergeron, C et al. (1996 b). Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol, 40, 428–39Google Scholar
Wilson, W, Mathew, R, Turkington, T, Hawk, T, Coleman, R E and Provenzale, J (2000). Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis, 19, 1–22CrossRefGoogle Scholar
Woolverton, W L, Ricaurte, G A, Forno, L S and Seiden, L S (1987). Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res, 486, 73–8CrossRefGoogle Scholar
Young, S N, Smith, S E, Pihl, R O and Ervin, F R (1985). Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology, 87, 173–7CrossRefGoogle Scholar

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×